Risk assessment exposure setting

While risk assessment in the context of protecting public health has been performed for many years, it is the 1983 U.S. National Academy of Sciences Report (Committee on the Institutional Means for Assessment of Risks to Public Health Commission on Life Sciences National Research Council 1983) that has served as the tenet for practicing risk assessors (see Chapter 1). Risk assessment was defined as the characterization of the potential adverse health effects of human exposures to environmental hazards. The predictive aspect of risk assessment was set by the use of the word potential. A fundamental expectation of the risk assessment process was that it should attempt to accm-ately predict adverse effects before there is evidence of disease in the population. Thus, risk assessment goes beyond the mere description of epidemiological and clinical case-control studies. In that report, the committee defined logical components of a risk assessment which still serve as guiding principles today. They were and are (a) hazard assessment or the qualitative determination that a stressor poses a hazard as evidence by causal evidence of an ill effect,... 

Hazard identification involves gathering and evaluating data on the types of health injury or disease that may be produced by a chemical and on the conditions of exposure under which injury or disease is produced. It may also involve characterization of the behavior of a chemical within the body and the interactions it undergoes with organs, cells, or even parts of cells. Hazard identification is not risk assessment. It is a scientific determination of whether observed toxic effects in one setting will occur in other settings. 

Most human or environmental healtli hazards can be evaluated by dissecting tlie analysis into four parts liazard identification, dose-response assessment or hazard assessment, exposure assessment, and risk characterization. For some perceived healtli liazards, tlie risk assessment might stop with tlie first step, liazard identification, if no adverse effect is identified or if an agency elects to take regulatory action witliout furtlier analysis. Regarding liazard identification, a hazard is defined as a toxic agent or a set of conditions that luis the potential to cause adverse effects to hmnan health or tlie environment. Healtli hazard identification involves an evaluation of various forms of information in order to identify the different liaz.ards. Dose-response or toxicity assessment is required in an overall assessment responses/cffects can vary widely since all chemicals and contaminants vary in their capacity to cause adverse effects. This step frequently requires that assumptions be made to relate... 

The output of an exposure and risk assessment will usually describe the levels of exposure and quantity the population exposed for both humans and other biota, and will estimate the associated probabilities of the incidence of adverse health effects. Population exposure or risk, obtained by multiplying the individual (per capita) exposure or risk by the numbers exposed at each level of exposure, may also be a useful measure of impact. Various analyses can be performed on the results, for example, comparison of exposures in a particular geographic area against national average exposure levels. Likewise, for the same pollutant, environmental risks due to a particular industry might be compared against risks associated with occupational or household activities. In addition, the health risk of different substances could be compared for priority setting. 

Table 3 describes the main parts of an environmental risk assessment (ERA) that are based on the two major elements characterisation of exposure and characterisation of effects [27, 51]. ERA uses a combination of exposure and effects data as a basis for assessing the likelihood and severity of adverse effects (risks) and feeds this into the decision-making process for managing risks. The process of assessing risk ranges from the simple calculation of hazard ratios to complex utilisation of probabilistic methods based on models and/or measured data sets. Setting of thresholds such as EQS and quality norms (QN) [27] relies primarily on... 

Immunotoxicology data most often available for use in risk assessment is derived from experimental animal studies. Although animal models provide an opportunity to establish more reliable exposure estimates and conduct more informative tests than human studies, the level of accuracy that can be achieved using such data in extrapolating to humans is often a matter of debate. In immunotoxicology testing, a set of tests usually referred to... 

Precautionary action to reduce the exposure of humans and wildlife to the oestrogenic plastics intermediate bisphenol A looks closer following an EC technical meeting in March. Member States rejected risk assessments put forward by the UK which set aside evidence of low-dose effects on fish and laboratory animals. Bisphenol A is an important plastics intermediate used in polycarbonates and epoxy resins. Global manufacturing capacity stands at two million tonnes per year. 

There are no occupational exposure limits for many hazardous substances which may require control of inhalation exposures. The necessary data and other resources required for setting such limits is restricted and unlikely to match the potential demand. A hazard categorisation scheme was, therefore, developed for application within the chemical industry. The scheme used readily-available information on toxicological endpoints to place hazardous substances into a limited range of hazard categories, expressed as Occupational Exposure Bands. These Bands could be used as a basis for risk assessment and the selection of appropriate control regimes. 10 refs. EUROPEAN COMMUNITY EUROPEAN UNION UK WESTERN EUROPE... 

Scientific evidence concerning toxic hazards and their dose-response characteristics for a particular substance is collected under one set of conditions (call it condition A), and is to be used to assess risks that might arise under different conditions of exposure to that substance (call this condition B). In some cases, the differences between conditions A and B are relatively small, but in many cases they are large. Risk assessment necessarily entails extrapolation from observations made under condition A to allow inferences to be made regarding what might be expected under condition B. Here are the major reasons why extrapolation is necessary. 

The data required for the risk assessment in relation to human health can be categorized as data on the identity of the substance, its physico-chemical and toxicological properties, and on exposure. The minimum data set required for a risk assessment depends on the chemical use category (industrial chemical, pesticide, biocide, food additive, food contact material, etc.), the regulation involved, and the goal of the risk assessment. This chapter will focus on the data used in the hazard assessment. 

In conclusion, the traditional assessment factors (interspecies, intraspecies, subchronic-to-chronic, LOAEL-to-NOAEL, and database-deficiency) are considered to cover the concerns and uncertainties for children adequately, i.e., no children-specific assessment factor is needed when setting tolerable intakes. However, it is recommended to perform children-specific risk assessments for chemical substances in products and foods intended for children, based on specific exposure assessments for children. 

FIGURE S.6 Schematic illustration of the traditional setting of an acceptable level of exposure (ADI) by dividing the NOAEL from an animal study by an assessment factor (AF). The two dose-response relationships have identical NOAEL. If a uniform assessment factor is applied, there will be an adequate MOS at the ADI for effect b but not for effect a. (Modified from KEMI, Human health risk assessment. Proposals for the use of assessment (uncertainty) factors. Application to risk assessment for plant protection products, industrial chemicals and biocidal products within the European Union. Report No. 1/03, Solna, Sweden, 2003. 

---